Apyx Medical
APYX
75 hedge funds and large institutions have $245M invested in Apyx Medical in 2021 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 31 reducing their positions, and 7 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
14% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 7
1% more funds holding
Funds holding: 74 → 75 (+1)
0.62% more ownership
Funds ownership: 55.02% → 55.64% (+0.62%)
6% less capital invested
Capital invested by funds: $261M → $245M (-$16.4M)
32% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EGI
EAM Global Investors
Solana Beach,
California
|
+$1.71M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$1.12M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$593K |
| 4 |
CAC
Cowen and Company
New York
|
+$322K |
| 5 |
BlackRock
New York
|
+$222K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
-$975K |
| 2 |
TFCM
Taylor Frigon Capital Management
Scottsdale,
Arizona
|
-$918K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$867K |
| 4 |
Goldman Sachs
New York
|
-$734K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$685K |
APYX Hedge Fund Activity: Q4 2021 in Review
75 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q4 2021, worth a combined $245M — down 6.3% from $261M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new APYX positions and 7 closed out — a net gain of 1 holder — while 21 added to existing stakes and 31 trimmed.
The largest buyer was EAM Global Investors, opening a new position worth an estimated $1.71M. The largest seller was Royce & Associates, cutting an estimated $975K.
- 75 institutional investors held Apyx Medical (APYX) as of Q4 2021, up from 74 in Q3 2021.
- Funds reported $245M of Apyx Medical stock for Q4 2021, down 6.3% quarter-over-quarter.
- 8 funds opened new Apyx Medical positions in Q4 2021 and 7 closed out, a net change of +1 holder.
- The largest Apyx Medical buyer in Q4 2021 was EAM Global Investors, an estimated $1.71M added.
- The largest Apyx Medical seller in Q4 2021 was Royce & Associates, an estimated $975K sold.
Based on aggregated 13F filings for Q4 2021.